{"id":"ais","safety":{"commonSideEffects":[{"rate":null,"effect":"Depression"},{"rate":null,"effect":"Anxiety"}]},"_chembl":{"chemblId":"CHEMBL4303677","moleculeType":"Small molecule","molecularWeight":"660.53"},"_dailymed":{"setId":"ab88474b-7fd5-8eae-e053-2a95a90ab99d","title":"AISLINN HAND SANITIZER GEL (ALCOHOL) GEL [ALCARAZ SILVA, HECTOR ALBERTO TONATHIÚ]"},"mechanism":{"_ai_source":"groq-llama-8b","explanation":"AIs work by leveraging machine learning algorithms to analyze and interpret complex neural signals, allowing for more accurate diagnoses and personalized treatment plans. This approach has shown promise in improving patient outcomes and quality of life for those affected by neurodegenerative diseases.","oneSentence":"AIs is a class of drugs that utilize artificial intelligence to enhance or restore cognitive function in patients with neurodegenerative diseases.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T03:20:26.579Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Treatment-resistant depression"},{"name":"Alzheimer's disease"}]},"trialDetails":[{"nctId":"NCT06592924","phase":"PHASE3","title":"Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response","status":"RECRUITING","sponsor":"Canadian Cancer Trials Group","startDate":"2025-05-28","conditions":"Prostate Cancer (Adenocarcinoma)","enrollment":830},{"nctId":"NCT05593497","phase":"PHASE2","title":"A Single-Arm Phase II Study of Neoadjuvant Intensified Androgen Deprivation (Leuprolide and Abiraterone Acetate) in Combination With AKT Inhibition (Capivasertib) for High-Risk Localized Prostate Cancer With PTEN Loss","status":"RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2024-05-31","conditions":"High-Risk Prostate Cancer","enrollment":30},{"nctId":"NCT06682702","phase":"NA","title":"Effectiveness of Dynamic Neuromuscular Stabilization Breathing Exercises With Schroth in Adolescent Idiopathic Scoliosis","status":"COMPLETED","sponsor":"Uskudar University","startDate":"2024-11-15","conditions":"Adolescent Idiopathic Scoliosis (AIS)","enrollment":26},{"nctId":"NCT01251861","phase":"PHASE2","title":"Bicalutamide With or Without Akt Inhibitor MK2206 in Treating Patients With Previously Treated Prostate Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2010-12-23","conditions":"Recurrent Prostate Carcinoma, Stage I Prostate Cancer AJCC v7, Stage IIA Prostate Cancer AJCC v7","enrollment":108},{"nctId":"NCT06733246","phase":"NA","title":"Safety and Efficacy Evaluation of the Ceretrieve Device in the Treatment of AIS Patients","status":"RECRUITING","sponsor":"Ceretrieve Ltd.","startDate":"2024-11-12","conditions":"Acute Ischemic Stroke","enrollment":132},{"nctId":"NCT04325828","phase":"PHASE2","title":"A Study of Apalutamide Combined With GnRH Agonist in Participants With Androgen Receptor Positive Salivary Gland Carcinoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Janssen Pharmaceutical K.K.","startDate":"2020-04-07","conditions":"Salivary Gland Neoplasms","enrollment":31},{"nctId":"NCT06863272","phase":"PHASE1, PHASE2","title":"A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2025-07-03","conditions":"Castration-Resistant Prostatic Cancer, Metastasis","enrollment":360},{"nctId":"NCT07491354","phase":"","title":"The Biopsychosocial Model to Identify Risk Factors for Chronic Post-traumatic Pain in ICU Patients","status":"RECRUITING","sponsor":"University Hospital, Montpellier","startDate":"2024-07-29","conditions":"Post Traumatic Chronic Pain","enrollment":400},{"nctId":"NCT06457919","phase":"PHASE1, PHASE2","title":"A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer","status":"RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2024-06-04","conditions":"Prostate Cancer","enrollment":50},{"nctId":"NCT07162064","phase":"PHASE3","title":"Heparin for RAO Post-Transradial Angiography in AIS","status":"COMPLETED","sponsor":"Xiang Luo","startDate":"2025-08-04","conditions":"Acute Ischemic Stroke","enrollment":440},{"nctId":"NCT05065216","phase":"PHASE2, PHASE3","title":"Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)","status":"RECRUITING","sponsor":"DiaMedica Therapeutics Inc","startDate":"2021-11-07","conditions":"Acute Stroke, Ischemic Stroke, Stroke","enrollment":728},{"nctId":"NCT07426094","phase":"PHASE2, PHASE3","title":"PRO-BOOST-N: Prostate-First Versus Combined Prostate and Nodal Dose Escalation in PSMA PET-Staged Node-Positive Prostate Cancer","status":"RECRUITING","sponsor":"Affidea Nu-med Center of Oncological DIagnostics and Therapy","startDate":"2026-03-19","conditions":"Prostate Cancer, Brachytherapy, Stereotactic Body Radiation Therapy (SBRT)","enrollment":1600},{"nctId":"NCT07103018","phase":"PHASE1","title":"A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)","status":"RECRUITING","sponsor":"K36 Therapeutics, Inc.","startDate":"2025-11-21","conditions":"Metastatic Castration-resistant Prostate Cancer, Metastatic Castration-Resistant Prostate Cancer Patients, Metastatic Castration-resistant Prostate Cancer, mCRPC","enrollment":144},{"nctId":"NCT04689828","phase":"PHASE3","title":"177Lu-PSMA-617 vs. Androgen Receptor-Directed Therapy in the Treatment of Progressive Metastatic Castrate Resistant Prostate Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2021-06-15","conditions":"Prostatic Neoplasms","enrollment":469},{"nctId":"NCT05658003","phase":"PHASE2","title":"A Study Evaluating [177Lu]Lu-PSMA-617 vs. a Change of Androgen Receptor-directed Therapy in Taxane Treatment Naive Chinese Male Patients With Progressive Metastatic Castrate Resistant Prostate Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2023-05-05","conditions":"Metastatic Castration-Resistant Prostate Cancer (mCRPC)","enrollment":63},{"nctId":"NCT07340541","phase":"PHASE2","title":"Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies","status":"NOT_YET_RECRUITING","sponsor":"UNC Lineberger Comprehensive Cancer Center","startDate":"2026-02","conditions":"Breast Cancer, Metastatic Breast Cancer, Triple Negative Breast Cancer","enrollment":700},{"nctId":"NCT04929678","phase":"NA","title":"Study of the Braive Growth Modulation System for Progressive Pediatric Scoliosis","status":"TERMINATED","sponsor":"Medtronic Spinal and Biologics","startDate":"2021-08-12","conditions":"Juvenile Idiopathic Scoliosis, Adolescent Idiopathic Scoliosis","enrollment":10},{"nctId":"NCT05573126","phase":"PHASE1, PHASE2","title":"Phase 1/2 Study to Evaluate EP0062 as Monotherapy and in Combination in Patients With Advanced or Metastatic AR+/HER-2-/ER+ Breast Cancer","status":"RECRUITING","sponsor":"Ellipses Pharma","startDate":"2023-01-11","conditions":"Hormone Receptor-positive Breast Cancer, Hormone Receptor Positive HER-2 Negative Breast Cancer, Metastatic Breast Cancer","enrollment":95},{"nctId":"NCT06705686","phase":"PHASE1","title":"Novel ACK1 Inhibitor (R)-9b in Patients With Prostate Cancer","status":"RECRUITING","sponsor":"TechnoGenesys, Inc.","startDate":"2026-03-13","conditions":"Metastatic Castration-resistant Prostate Cancer (CRPC), Metastatic Castration-resistant Prostate Carcinoma","enrollment":40},{"nctId":"NCT06169124","phase":"PHASE2","title":"Study to Test the Drug Darolutamide Along With the Drugs Leuprolide Acetate and Exemestane in Patients With Recurrent Ovarian Granulosa Cell Tumors","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2024-02-08","conditions":"Adult Ovarian Granulosa Cell Tumor","enrollment":37},{"nctId":"NCT07477756","phase":"","title":"A Real-world Study of Characteristics, Treatment Patterns, and Clinical Outcomes Among Lutetium-177 Vipivotide Tetraxetan Treated Patients","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2024-09-04","conditions":"Prostate Cancer","enrollment":1247},{"nctId":"NCT07482748","phase":"NA","title":"Diaphragm Mobilization in Adolescent Idiopathic Scoliosis","status":"NOT_YET_RECRUITING","sponsor":"Marmara University","startDate":"2026-03-15","conditions":"Adolescent Idiopathic Scoliosis","enrollment":42},{"nctId":"NCT07107022","phase":"","title":"Study to Collect Real-world Performance and Safety Data on Penumbra System® in Population With Acute Ischemic Stroke (AIS).","status":"RECRUITING","sponsor":"Penumbra Inc.","startDate":"2025-11-01","conditions":"Acute Ischemic Stroke (AIS)","enrollment":200},{"nctId":"NCT07481071","phase":"","title":"Cyberchondria in Adolescents With Idiopathic Scoliosis","status":"NOT_YET_RECRUITING","sponsor":"Izmir Democracy University","startDate":"2026-03-15","conditions":"Scoliosis Idiopathic Adolescent, Cyberchondria","enrollment":100},{"nctId":"NCT07428642","phase":"","title":"PSMA PET/CT-Based Multimodal Model for Predicting Response to First-Line Therapy in mHSPC.","status":"COMPLETED","sponsor":"First Affiliated Hospital of Wenzhou Medical University","startDate":"2020-09-01","conditions":"Metastatic Hormone-Sensitive Prostate Cancer, Prostate Cancer","enrollment":168},{"nctId":"NCT03904914","phase":"","title":"Thumb Ossification Composite Index (TOCI) to Predict Skeletal Maturity and Curve Progression in AIS","status":"COMPLETED","sponsor":"Chinese University of Hong Kong","startDate":"2016-09-01","conditions":"Scoliosis; Adolescence, Bone Diseases, Bone Growth Abnormal","enrollment":1500},{"nctId":"NCT07209852","phase":"","title":"Safety, Performance, and Clinical Benefit of Pacing the Left Bundle Branch Area - Post-Market Clinical Follow-up","status":"RECRUITING","sponsor":"Boston Scientific Corporation","startDate":"2025-12-19","conditions":"Bradycardia, Atrioventricular Block, Sinus Node Dysfunction","enrollment":140},{"nctId":"NCT04708431","phase":"","title":"Androgen Receptor, Implications for Health and Wellbeing: Natural History Study of Individuals With Androgen Insensitivity","status":"RECRUITING","sponsor":"Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)","startDate":"2021-04-29","conditions":"Androgen Insensitivity Syndrome, Metabolic Parameters in AIS, CAIS, PAIS and MAIS, Tumor Formation in AIS, CAIS, PAIS and MAIS","enrollment":650},{"nctId":"NCT07335796","phase":"PHASE2","title":"A Study of BMS986365 in Combination With Degarelix in People With Prostate Cancer","status":"RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2026-01-09","conditions":"Prostate Cancer","enrollment":30},{"nctId":"NCT05800717","phase":"PHASE1, PHASE2","title":"Self-Management Program for AIS D SCI","status":"WITHDRAWN","sponsor":"VA Office of Research and Development","startDate":"2024-05-01","conditions":"Psychological Well-Being, Spinal Cord Injuries","enrollment":""},{"nctId":"NCT04662580","phase":"PHASE1","title":"ARX517/JNJ-95298177 as Monotherapy or Combination Therapy in Subjects With Metastatic Prostate Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2021-05-03","conditions":"Metastatic Prostate Cancer","enrollment":183},{"nctId":"NCT03523442","phase":"PHASE1","title":"A Study of Androgen Receptor (AR) Antagonist Apalutamide in Chinese Participants With Metastatic Castration-Resistant Prostate Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2018-08-31","conditions":"Prostatic Neoplasms","enrollment":19},{"nctId":"NCT05022849","phase":"PHASE1","title":"A Study of JNJ-75229414 for Metastatic Castration-resistant Prostate Cancer Participants","status":"ACTIVE_NOT_RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2021-09-28","conditions":"Prostatic Neoplasms","enrollment":15},{"nctId":"NCT06365892","phase":"NA","title":"Open-label Placebo (COLP) for Pain in Adolescent Idiopathic Scoliosis (AIS) Surgery+Surgical Treatment of Idiopathic Scoliosis","status":"RECRUITING","sponsor":"University of California, San Francisco","startDate":"2024-07-01","conditions":"Adolescent Idiopathic Scoliosis (AIS)","enrollment":64},{"nctId":"NCT07466498","phase":"PHASE2","title":"Estrogen to Improve Quality of Life for Men With Newly Diagnosed or Recurrent Metastatic Hormone Sensitive Prostate Cancer, EQUIP Trial","status":"NOT_YET_RECRUITING","sponsor":"University of Washington","startDate":"2026-08-01","conditions":"Castration-Sensitive Prostate Adenocarcinoma, Metastatic Castration-Sensitive Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8","enrollment":60},{"nctId":"NCT06380751","phase":"PHASE3","title":"Saruparib (AZD5305) Plus Camizestrant Compared With CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant in HR-Positive, HER2-Negative (IHC 0, 1+, 2+/ ISH Non-amplified), BRCA1, BRCA2, or PALB2m Advanced Breast Cancer","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2024-08-01","conditions":"Advanced Breast Cancer","enrollment":500},{"nctId":"NCT04944940","phase":"","title":"Clinical, Molecular and Imaging Biomarkers in Spinal and Bulbar Muscular Atrophy (SBMA)","status":"RECRUITING","sponsor":"National Institute of Neurological Disorders and Stroke (NINDS)","startDate":"2021-10-25","conditions":"Spinal and Bulbar Muscular Atrophy, Kennedys Disease, Motor Neuron Disease","enrollment":70},{"nctId":"NCT07142551","phase":"PHASE2","title":"Supraphysiologic Testosterone Priming Induces Darolutamide Extended Response","status":"RECRUITING","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","startDate":"2026-03-09","conditions":"Metastatic Castration-resistant Prostate Cancer","enrollment":60},{"nctId":"NCT06265051","phase":"PHASE2, PHASE3","title":"Tirofiban After Successful MT Recanalization in AIS","status":"COMPLETED","sponsor":"Xiang Luo","startDate":"2024-04-09","conditions":"Acute Ischemic Stroke, Vessel Occlusion","enrollment":1380},{"nctId":"NCT07456722","phase":"","title":"Cardiac Morphology and Function in Individuals With Autonomic Dysreflexia","status":"NOT_YET_RECRUITING","sponsor":"Swiss Paraplegic Research, Nottwil","startDate":"2026-05-01","conditions":"Autonomic Dysreflexia, Spinal Cord Injuries and Disorders (SCI/D), Cardiac Remodeling","enrollment":48},{"nctId":"NCT04720157","phase":"PHASE3","title":"An International Prospective Open-label, Randomized, Phase III Study Comparing 177Lu-PSMA-617 in Combination With Standard of Care (SoC), Versus SoC Alone, in Adult Male Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2021-06-09","conditions":"Prostatic Neoplasms","enrollment":1145},{"nctId":"NCT07182279","phase":"PHASE1, PHASE2","title":"Neoadjuvant High Dose Rate Brachytherapy Prior to Radical Prostatectomy in Patients With Prostate Cancer","status":"RECRUITING","sponsor":"The Methodist Hospital Research Institute","startDate":"2025-08-01","conditions":"Prostate Cancer (Adenocarcinoma)","enrollment":29},{"nctId":"NCT04761549","phase":"NA","title":"3D, Dynamic and Mechanically-informed Decision Making in AIS","status":"RECRUITING","sponsor":"Universitaire Ziekenhuizen KU Leuven","startDate":"2021-01-19","conditions":"Adolescent Idiopathic Scoliosis","enrollment":100},{"nctId":"NCT06463457","phase":"PHASE2","title":"Comeback From Long coursE Androgen Deprivation Therapy (ADT) With RElugolix and Darolutamide (CLEARED)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Atish Choudhury, MD","startDate":"2024-12-13","conditions":"Prostate Cancer, Advanced Prostate Cancer, Hormone Sensitive Prostate Cancer","enrollment":33},{"nctId":"NCT07375745","phase":"NA","title":"Spinal Stimulation With Gait Training to Improve Lower Limbs Motor Recovery in Spinal Cord Injury","status":"NOT_YET_RECRUITING","sponsor":"Centre for Interdisciplinary Research in Rehabilitation of Greater Montreal","startDate":"2026-07-01","conditions":"Spinal Cord Injury, Spinal Cord Injury Subacute, Locomotion","enrollment":40},{"nctId":"NCT06691984","phase":"PHASE3","title":"Phase 3 Study of Xaluritamig vs Cabazitaxel or Second Androgen Receptor-Directed Therapy in Participants With Progressive Metastatic Castration-Resistant Prostate Cancer (XALute)","status":"RECRUITING","sponsor":"Amgen","startDate":"2024-12-09","conditions":"Metastatic Castration-resistant Prostate Cancer","enrollment":675},{"nctId":"NCT04423679","phase":"","title":"The Selfie Study- Assessing Novel Markers for Cervical Cancer Screening From Self-collected Samples","status":"COMPLETED","sponsor":"George Washington University","startDate":"2020-08-15","conditions":"Human Papilloma Virus, Cervical Cancer, CIN 2/3","enrollment":294},{"nctId":"NCT07285551","phase":"NA","title":"Physiotherapy and Whole-Body Vibration in Adolescent Idiopathic Scoliosis","status":"COMPLETED","sponsor":"Gdansk University of Physical Education and Sport","startDate":"2026-02-15","conditions":"Scoliosis Idiopathic Adolescent Treatment, Whole-body Vibration","enrollment":50},{"nctId":"NCT07448688","phase":"NA","title":"Effects of Lumbar Traction Combined With 3D Exercise Therapy on Adolescent Idiopathic Scoliosis","status":"NOT_YET_RECRUITING","sponsor":"Şahide Eda ARTUÇ","startDate":"2026-03-05","conditions":"Adolescent Idiopathic Scoliosis (AIS), Exercise (EX)","enrollment":40},{"nctId":"NCT05849298","phase":"PHASE2","title":"A Phase II Study of AAA617 Alone and AAA617 in Combination With ARPI in Patients With PSMA PET Scan Positive CRPC","status":"ACTIVE_NOT_RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2024-01-03","conditions":"Prostatic Neoplasm","enrollment":49},{"nctId":"NCT06411912","phase":"PHASE2","title":"A Study of NIDO-361 in Patients With SBMA","status":"COMPLETED","sponsor":"Nido Biosciences, Inc.","startDate":"2024-03-01","conditions":"Spinal and Bulbar Muscular Atrophy, Kennedy's Disease","enrollment":54},{"nctId":"NCT07321600","phase":"NA","title":"Resisted Inspiratory Muscle Training Applied in Addition to PSSE-Schroth Exercises","status":"RECRUITING","sponsor":"Hacettepe University","startDate":"2026-01-02","conditions":"Adolescence Idiopathic Scoliosis","enrollment":45},{"nctId":"NCT07206056","phase":"PHASE1, PHASE2","title":"An Open-label Dose Escalation and Expansion, Followed by a Phase II Study of Tulmimetostat (DZR123) and JSB462 (Luxdegalutamide) in Patients With Progressive Metastatic Castrate Resistant Prostate Cancer (mCRPC) (TulmiSTAR-01)","status":"RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2025-10-15","conditions":"Progressive Metastatic Castrate Resistant Prostate Cancer","enrollment":188},{"nctId":"NCT07047118","phase":"PHASE2","title":"A Study of JSB462 (Luxdegalutamide) Plus Lutetium (177Lu) Vipivotide Tetraxetan in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)","status":"RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2025-07-03","conditions":"Prostatic Cancer, Castration-Resistant","enrollment":130},{"nctId":"NCT04597125","phase":"PHASE4","title":"RADIANT: A Study of Radium-223 Dichloride (Xofigo) vs Enzalutamide or Abiraterone (ARPIs, Androgen Receptor Pathway Inhibitors) in Patients With Prostate Cancer That Has Spread to the Bones (mCRPC, Metastatic Castration-Resistant Prostate Cancer)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Bayer","startDate":"2020-11-09","conditions":"Metastatic Castrate Resistant Prostate Cancer (mCRPC)","enrollment":654},{"nctId":"NCT07190300","phase":"PHASE1, PHASE2","title":"TulmiSTAR-02: A Phase I/II Open-label Study of Tulmimetostat in Combination With Darolutamide vs. Darolutamide, and Tulmimetostat With Abiraterone in Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)","status":"RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2026-01-13","conditions":"Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)","enrollment":155},{"nctId":"NCT07443449","phase":"","title":"International SBMA Project (KDA)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta","startDate":"2024-07-29","conditions":"SBMA, Spinal and Bulbar Muscular Atrophy (SBMA)","enrollment":700},{"nctId":"NCT00448448","phase":"NA","title":"Bracing in Adolescent Idiopathic Scoliosis Trial (BrAIST)","status":"TERMINATED","sponsor":"Stuart L. Weinstein, MD","startDate":"2007-02","conditions":"Adolescent Idiopathic Scoliosis","enrollment":383},{"nctId":"NCT05700903","phase":"PHASE4","title":"Contributions to Hypertension With Androgen Deprivation Therapy","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2023-09-20","conditions":"Androgen Deprivation Therapy, Prostate Cancer, Hypertension","enrollment":10},{"nctId":"NCT04104893","phase":"PHASE2","title":"A Study of CHeckpoint Inhibitors in Men With prOgressive Metastatic Castrate Resistant Prostate Cancer Characterized by a Mismatch Repair Deficiency or Biallelic CDK12 Inactivation","status":"ACTIVE_NOT_RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2020-02-20","conditions":"Metastatic Castration Resistant Prostate Cancer","enrollment":40},{"nctId":"NCT06099769","phase":"PHASE2","title":"A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer","status":"RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2023-10-18","conditions":"Metastatic Breast Cancer","enrollment":201},{"nctId":"NCT07430917","phase":"PHASE2","title":"Safety and Efficacy of J147 in Acute Ischemic Stroke","status":"NOT_YET_RECRUITING","sponsor":"Abrexa Pharmaceuticals, Inc.","startDate":"2026-03-20","conditions":"Acute Ischemic Stroke","enrollment":196},{"nctId":"NCT07430098","phase":"NA","title":"Feedback-Based Balance Training for Adolescents With Idiopathic Scoliosis","status":"RECRUITING","sponsor":"Ankara Etlik City Hospital","startDate":"2025-04-04","conditions":"Adolescent Idiopathic Scoliosis (AIS)","enrollment":60},{"nctId":"NCT03016741","phase":"PHASE4","title":"Cognitive Effects of Androgen Receptor Directed Therapies for Advanced Prostate Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Northwestern University","startDate":"2017-03-31","conditions":"Castration-Resistant Prostatic Cancer, Metastatic Prostate Carcinoma, Recurrent Prostate Carcinoma","enrollment":100},{"nctId":"NCT06855277","phase":"PHASE3","title":"Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC","status":"RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2025-07-01","conditions":"Prostate Cancer","enrollment":940},{"nctId":"NCT06314594","phase":"NA","title":"Personalized Prevention and Treatment Strategies for Adolescent Idiopathic Scoliosis Via a Comprehensive Health Management Platform","status":"RECRUITING","sponsor":"Hangzhou Medical College","startDate":"2025-08-01","conditions":"Adolescent Idiopathic Scoliosis (AIS)","enrollment":76},{"nctId":"NCT05720130","phase":"PHASE1, PHASE2","title":"Phase Ib/IIa Dose Escalation and Expansion Study of [²¹²Pb]Pb-ADVC001 in Metastatic Prostate Cancer (TheraPb - Phase I/II Study).","status":"RECRUITING","sponsor":"AdvanCell Pty Limited","startDate":"2023-03-15","conditions":"Prostate Cancer, Metastatic Castration-resistant Prostate Cancer, Metastatic Hormone Sensitive Prostate Cancer","enrollment":100},{"nctId":"NCT07413588","phase":"NA","title":"Implementation of Specific Tailored Exercises Program Versus Exergaming Exercises on Cobb Angle in the Treatment of Adolescent Idiopathic Scoliosis.","status":"NOT_YET_RECRUITING","sponsor":"Cairo University","startDate":"2026-02-10","conditions":"Idiopathic Scoliosis","enrollment":54},{"nctId":"NCT06894511","phase":"PHASE2","title":"An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) in Combination With ARPI Versus AAA617 in PSMA Positive First-line mCRPC","status":"ACTIVE_NOT_RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2025-09-11","conditions":"Metastatic Castration Resistant Prostate Cancer (mCRPC)","enrollment":7},{"nctId":"NCT04983095","phase":"NA","title":"Metastasis Directed Stereotactic Body Radiotherapy for Oligo Metastatic Hormone Sensitive Prostate Cancer","status":"RECRUITING","sponsor":"Karin Soderkvist","startDate":"2021-10-27","conditions":"Prostate Cancer Metastatic, Radiation Therapy, Positron-Emission Tomography","enrollment":118},{"nctId":"NCT03858244","phase":"","title":"Idiopathic Scoliosis Progression and Sleep-disordered Breathing in Children","status":"ACTIVE_NOT_RECRUITING","sponsor":"Second Affiliated Hospital of Wenzhou Medical University","startDate":"2019-02-18","conditions":"Scoliosis Idiopathic, Sleep Disordered Breathing, Obstructive Sleep Apnea","enrollment":405},{"nctId":"NCT05647564","phase":"NA","title":"PET/CT Characterization of Treatment Resistance","status":"RECRUITING","sponsor":"University of Wisconsin, Madison","startDate":"2023-03-06","conditions":"Prostate Cancer","enrollment":25},{"nctId":"NCT07226986","phase":"PHASE1, PHASE2","title":"A Phase Ib/II Open-label Study of AMO959 With Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) in Combination With ARPI in Adult Participants With PSMA-positive mCRPC","status":"RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2025-12-05","conditions":"PSMA-positive Metastatic Castration Resistant Prostate Cancer (mCRPC) With Prior Exposure to One Prior ARPI Who Are Candidates for Taxane-based Chemotherapy","enrollment":123},{"nctId":"NCT05818683","phase":"PHASE1","title":"A Study of JNJ-78278343 in Combination With Either JNJ-63723283 (Cetrelimab), Taxane Chemotherapy, or Androgen Receptor Pathway Inhibitors for Metastatic Prostate Cancer","status":"RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2023-04-26","conditions":"Metastatic Castration-resistant Prostate Neoplasms, Metastatic Hormone-sensitive Prostate Cancer","enrollment":277},{"nctId":"NCT07408843","phase":"","title":"Correlation Between Trunk Postural Changes by Mobile Application and Radiological Findings in Adolescent Idiopathic Scoliotic Females","status":"COMPLETED","sponsor":"Beni-Suef University","startDate":"2024-09-01","conditions":"Adolescent Idiopathic Scoliosis (AIS)","enrollment":30},{"nctId":"NCT07140900","phase":"PHASE1","title":"Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate Cancer","status":"RECRUITING","sponsor":"Amgen","startDate":"2025-10-07","conditions":"Metastatic Hormone-sensitive Prostate Cancer (mHSPC)","enrollment":60},{"nctId":"NCT05670106","phase":"PHASE2","title":"A Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Dosimetry of [177Lu]Lu-PSMA-617 in Chinese Adult Male Patients With Progressive PSMA-Positive mCRPC","status":"ACTIVE_NOT_RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2023-05-16","conditions":"Metastatic Castration-Resistant Prostate Cancer (mCRPC)","enrollment":62},{"nctId":"NCT05683964","phase":"EARLY_PHASE1","title":"Androgen Receptor Signaling and Prostate-Specific Membrane Antigen Expression","status":"ACTIVE_NOT_RECRUITING","sponsor":"Beth Israel Deaconess Medical Center","startDate":"2023-01-19","conditions":"Prostate Adenocarcinoma, Prostate Cancer, Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)","enrollment":9},{"nctId":"NCT07406282","phase":"","title":"A Study to Learn About Real-world Utilization and Outcomes of Darolutamide and Other Androgen Receptor Pathway Inhibitors (ARPIs) for Newly Diagnosed Metastatic Hormone-sensitive Prostate Cancer (de Novo mHSPC) in US Urology Clinics","status":"RECRUITING","sponsor":"Bayer","startDate":"2025-07-22","conditions":"Prostatic Neoplasms, Metastatic Hormone-Sensitive Prostate Cancer","enrollment":1400},{"nctId":"NCT07405762","phase":"","title":"Early Neurovascular Decoupling Trajectories After Revascularization in Acute Ischemic Stroke","status":"NOT_YET_RECRUITING","sponsor":"Xijing Hospital","startDate":"2026-02-05","conditions":"Ischemic Stroke","enrollment":180},{"nctId":"NCT07405112","phase":"","title":"Impact of Curve Magnitude on Pain and Body Image in Patients With Adolescents Idiopathic Scoliosis","status":"COMPLETED","sponsor":"Antalya Training and Research Hospital","startDate":"2024-09-23","conditions":"Adolescent Idiopathic Scoliosis (AIS), Back Pain, Back Pain Lower Back","enrollment":78},{"nctId":"NCT02749903","phase":"PHASE2","title":"Enzalutamide for Patients With Androgen Receptor Positive Salivary Cancers","status":"ACTIVE_NOT_RECRUITING","sponsor":"Alliance for Clinical Trials in Oncology","startDate":"2016-09-14","conditions":"Salivary Cancer","enrollment":46},{"nctId":"NCT07074873","phase":"","title":"Assessment of Pelvic Floor Muscle Activation in Adolescents With Idiopathic Scoliosis","status":"COMPLETED","sponsor":"Gaziosmanpasa Research and Education Hospital","startDate":"2024-09-19","conditions":"Pelvic Floor Muscle Activation, Idiopathic Scoliosis","enrollment":20},{"nctId":"NCT07252726","phase":"PHASE4","title":"Evaluating Dose Timing (Morning vs Evening) of Endocrine-based Therapies in Metastatic Breast and Prostate Cancers","status":"RECRUITING","sponsor":"Ottawa Hospital Research Institute","startDate":"2026-02-02","conditions":"Metastatic Breast Cancer, Metastatic Prostate Cancer","enrollment":50},{"nctId":"NCT05059236","phase":"PHASE2","title":"A Study to Learn How Well Darolutamide Administered Together With Androgen Deprivation Therapy (ADT) Works in Men With Metastatic Hormone-sensitive Prostate Cancer. Results Will be Compared With ADT Alone From a Previously Conducted Study.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Bayer","startDate":"2021-11-04","conditions":"Metastatic Hormone-sensitive Prostate Cancer","enrollment":223},{"nctId":"NCT06631521","phase":"PHASE1","title":"Neoadjuvant Darolutamide and Relugolix Combination Preceding Radical Prostatectomy for Prostate Cancer","status":"RECRUITING","sponsor":"AdventHealth","startDate":"2024-10-22","conditions":"Prostate CA, Prostate Cancer (Adenocarcinoma), Prostate Cancer Surgery","enrollment":30},{"nctId":"NCT05561725","phase":"PHASE4","title":"Perioperative Steroid Dosing on the APR in AIS","status":"RECRUITING","sponsor":"Emory University","startDate":"2023-01-03","conditions":"Adolescent Idiopathic Scoliosis (AIS)","enrollment":50},{"nctId":"NCT07389096","phase":"PHASE4","title":"Opioid-Free Anesthesia Versus Opioid Based Anesthesia For Adolescent Idiopathic Scoliosis","status":"RECRUITING","sponsor":"Nashwa Ahmed","startDate":"2026-01-30","conditions":"Opioid Free Anesthesia","enrollment":30},{"nctId":"NCT04573231","phase":"PHASE2","title":"Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer","status":"RECRUITING","sponsor":"University of Wisconsin, Madison","startDate":"2021-05-24","conditions":"Breast Cancer, HER2-negative Breast Cancer, Metastatic Breast Cancer","enrollment":13},{"nctId":"NCT07389174","phase":"EARLY_PHASE1","title":"Safety and Efficacy Evaluation of LC-K76 in Patients With Metastatic Hormone-Sensitive Prostate Cancer","status":"NOT_YET_RECRUITING","sponsor":"Shanghai Changzheng Hospital","startDate":"2026-02","conditions":"mHSPC, mHNPC, Prostate Cancer Adenocarcinoma","enrollment":40},{"nctId":"NCT07391488","phase":"","title":"The Effects of Lumbopelvic Rhythm on Postural Control, Daily Activities, and Quality of Life in Individuals With AIS","status":"ENROLLING_BY_INVITATION","sponsor":"Hacettepe University","startDate":"2025-12-30","conditions":"Adolescence Idiopathic Scoliosis","enrollment":50},{"nctId":"NCT04729114","phase":"PHASE1","title":"A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer","status":"RECRUITING","sponsor":"Astellas Pharma Global Development, Inc.","startDate":"2021-06-14","conditions":"Prostate Cancer, Metastatic Castration Resistant Prostate Cancer, Metastatic Castration-sensitive Prostate Cancer","enrollment":174},{"nctId":"NCT07311694","phase":"PHASE3","title":"A Phase III Study Comparing HRS-4357 With Novel Androgen Receptor Pathway Inhibitors in Patients With Progressive, PSMA-Positive Metastatic Castration-Resistant Prostate Cancer","status":"RECRUITING","sponsor":"Jiangsu HengRui Medicine Co., Ltd.","startDate":"2026-02-02","conditions":"PSMA-Positive Progressive Metastatic Castration-Resistant Prostate Cancer","enrollment":370},{"nctId":"NCT07223385","phase":"PHASE2","title":"High Cardiovascular Risk Intervention With Cardio-Oncology Consultation for Prostate Cancer Following Androgen Receptor Pathway Inhibitor (ARPI) Therapy (Heart-Safe)","status":"NOT_YET_RECRUITING","sponsor":"Cedars-Sinai Medical Center","startDate":"2026-04","conditions":"Prostate Cancer (Diagnosis), Prostate Cancer Stage IV, CV Risk","enrollment":80},{"nctId":"NCT04946370","phase":"PHASE1, PHASE2","title":"Phase I/II Trial of Pembrolizumab and Androgen-receptor Inhibitor With or Without 225Ac-J591 for Progressive Metastatic Castration Resistant Prostate Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Weill Medical College of Cornell University","startDate":"2021-08-12","conditions":"Prostate Cancer","enrollment":37},{"nctId":"NCT07383077","phase":"","title":"Molecular Determinants of Spinal Cord Injury Rehabilitation","status":"COMPLETED","sponsor":"Prof. Sandra Vieira","startDate":"2021-05-01","conditions":"Spinal Cord Injury","enrollment":106},{"nctId":"NCT06569030","phase":"NA","title":"Effect Spinal Orthosis on Sagittal and Frontal Parameters in Scoliosis","status":"COMPLETED","sponsor":"Istanbul Medipol University Hospital","startDate":"2024-11-21","conditions":"Adolescent Idiopathic Scoliosis","enrollment":30},{"nctId":"NCT06836726","phase":"PHASE2","title":"Clinical Trial to Test Efficacy of Targeting Hypoxia Combined With ARSI After First-line ARSI Therapy for Castrate Resistant Prostate Cancer","status":"NOT_YET_RECRUITING","sponsor":"University Health Network, Toronto","startDate":"2026-05-27","conditions":"Castration Resistant Prostate Cancer","enrollment":35},{"nctId":"NCT06764485","phase":"PHASE3","title":"A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer","status":"RECRUITING","sponsor":"Celgene","startDate":"2025-03-13","conditions":"Metastatic Castration-resistant Prostate Cancer","enrollment":960},{"nctId":"NCT04989946","phase":"PHASE1, PHASE2","title":"Androgen Deprivation, With or Without pTVG-AR, and With or Without T-Cell Checkpoint Blockade, in Patients With Newly Diagnosed, High-Risk Prostate Cancer","status":"RECRUITING","sponsor":"University of Wisconsin, Madison","startDate":"2021-12-16","conditions":"Prostate Cancer","enrollment":60}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":26504,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"AIs","genericName":"AIs","companyName":"Sun Yat-sen University","companyId":"sun-yat-sen-university","modality":"Small molecule","firstApprovalDate":"","aiSummary":"AIs is a class of drugs that utilize artificial intelligence to enhance or restore cognitive function in patients with neurodegenerative diseases. Used for Treatment-resistant depression, Alzheimer's disease.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}